世界中西医结合杂志
世界中西醫結閤雜誌
세계중서의결합잡지
WORLD JOURNAL OF TRADITIONAL CHINESE AND WESTERN MEDICINE
2014年
5期
467-469
,共3页
肺癌%经验方%温阳%病机%化痰散结%一扶三保
肺癌%經驗方%溫暘%病機%化痰散結%一扶三保
폐암%경험방%온양%병궤%화담산결%일부삼보
Lung Cancer%Experienced Formula%Warming Yang%Pathogenesis%Resolving Phlegm and Eliminating Masses%One Strengthening Approach and Three Protective Measures
在2013年10月召开的第22届亚太抗癌大会上,中国工程院院士郝希山说:“亚太地区癌症新增病例占到全球癌症新增病例的45%,死亡人数约占全球癌症死亡人数的一半,肺癌、胃癌和肝癌是亚洲国家最常见的3种癌症。目前,肺癌是亚洲国家面临的最主要癌症。”肺癌属于疑难病,挖掘有效的治疗方法已是医学界热门的研究课题。贾文魁教授对肺癌的中医治疗有着丰富的临床经验,从临床角度提出“温阳散结化癌瘤、肺癌重在虚和痰、一扶三保贯始终”等一系列治疗方法和思想,在肺癌的临床治疗中取得了满意的效果。
在2013年10月召開的第22屆亞太抗癌大會上,中國工程院院士郝希山說:“亞太地區癌癥新增病例佔到全毬癌癥新增病例的45%,死亡人數約佔全毬癌癥死亡人數的一半,肺癌、胃癌和肝癌是亞洲國傢最常見的3種癌癥。目前,肺癌是亞洲國傢麵臨的最主要癌癥。”肺癌屬于疑難病,挖掘有效的治療方法已是醫學界熱門的研究課題。賈文魁教授對肺癌的中醫治療有著豐富的臨床經驗,從臨床角度提齣“溫暘散結化癌瘤、肺癌重在虛和痰、一扶三保貫始終”等一繫列治療方法和思想,在肺癌的臨床治療中取得瞭滿意的效果。
재2013년10월소개적제22계아태항암대회상,중국공정원원사학희산설:“아태지구암증신증병례점도전구암증신증병례적45%,사망인수약점전구암증사망인수적일반,폐암、위암화간암시아주국가최상견적3충암증。목전,폐암시아주국가면림적최주요암증。”폐암속우의난병,알굴유효적치료방법이시의학계열문적연구과제。가문괴교수대폐암적중의치료유착봉부적림상경험,종림상각도제출“온양산결화암류、폐암중재허화담、일부삼보관시종”등일계렬치료방법화사상,재폐암적림상치료중취득료만의적효과。
On the 22nd Asia Pacific Conference on Anticancer held in October 2013,Prof. Hao Xis-han,the academician of Chinese Academy of Engineering said:“the new cases of cancer in the Asia Pacific Region accounted for 45% of the total increased cases in the world. The death cases occupied the half of the total number in the world. Lung cancer,stomach cancer and liver cancer are the most common cancers in Asi-an countries. At present,lung cancer is the main one facing to Asian countries”. Lung cancer is the intracta-ble disease. Digging an effective therapeutic method had become the top research topic in medical field. Prof. Jia Wenkui has accumulated rich clinical experiences in the treatment of lung cancer with TCM. In view of clinical practice,a series of therapeutic methods and thoughts had been proposed,such as“warming yang,re-solving masses,emphasizing on the deficiency and phlegm in treatment of lung cancer,integration of one strengthening approach and three protective measures”. The satisfactory effect has been achieved in the clini-cal treatment of lung cancer.